Regulation of cell growth by oxidized LDL

Free Radical Biology and Medicine

Volumn 28, Issue 12, 2000, Pages 1697-1707

  Chisolm III, Guy M ^a   Chai, Yuh Cherng ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Antioxidant; Atherosclerosis; Endothelial cell; Free radicals; Growth factor; Macrophage; Oxidized LDL; Smooth muscle cells

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; SCAVENGER RECEPTOR;

ANIMAL CELL; CELL GROWTH; CELL TYPE; CYTOKINE PRODUCTION; CYTOTOXICITY; LIPID OXIDATION; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REVIEW; SMOOTH MUSCLE FIBER;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0034659167     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00227-6     Document Type: Article

References (128)

1. Hessler J.R., Morel D.W., Lewis L.J., Chisolm G.M. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis. 3:1983;215-222.
2. Morel D.W., Hessler J.R., Chisolm G.M. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J. Lipid Res. 24:1983;1070-1076.
3. Morel D.W., DiCorleto P.E., Chisolm G.M. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis. 4:1984;357-364.
4. Steinbrecher U.P., Parthasarathy S., Leake D.S., Witztum J.L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA. 81:1984;3883-3887.
5. Augustyn J., Fritz K.E., Daoud A.S., Jarmolych J. Effect of lipoprotein on in vitro synthesis of DNA in aortic tissue. Adv. Exp. Med. Biol. 82:1977;246-248.
6. Brown B.G., Mahley R., Assmann G. Swine aortic smooth muscle in tissue culture. Some effects of purified swine lipoproteins on cell growth and morphology. Circ. Res. 39:1976;415-424.
7. Fischer-Dzoga K., Fraser R., Wissler R.W. Stimulation of proliferation in stationary primary cultures of monkey and rabbit aorta smooth muscle cells. I. Effects of lipoprotein fractions of hyperlipemic serum and lymph. Exp. Mol. Pathol. 24:1976;346-359.
8. Hessler J.R., Robertson A.L. Jr, Chisolm G.M. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis. 32:1979;213-229.
9. Henriksen T., Evensen S.A., Carlander B. Injury to human endothelial cells in culture induced by low-density lipoproteins. Scand. J. Clin. Lab. Invest. 39:1979;361-368.
10. Kosugi K., Morel D.W., DiCorleto P.E., Chisolm G.M. Toxicity of oxidized low-density lipoprotein to cultured fibroblasts is selective for S phase of the cell cycle. J. Cell. Physiol. 130:1987;311-320.
11. Fox P.L., Chisolm G.M., DiCorleto P.E. Lipoprotein mediated inhibition of endothelial cell production of platelet-derived growth factor-like proteins depends on free radical lipid peroxidation. J. Biol. Chem. 262:1987;6046-6054.
12. Hamilton T.A., Ma G., Chisolm G.M. Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-alpha mRNA in stimulated murine peritoneal macrophages. J. Immunol. 144:1990;2343-2350.
13. Rajavashisth T.B., Andalibi A., Territo M.C., Berliner J.A., Navab M., Fogelman A.M., Lusis A.J. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature. 344:1990;254-257.
14. Auge N., Pieraggi M.-T., Thiers J.-C., Negre-Salvayre A., Salvayre R. Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells. Biochem. J. 309:1995;1015-1020.
15. Rangaswamy S., Penn M.S., Saidel G.M., Chisolm G.M. Exogenous oxidized low-density lipoprotein injures and alters the barrier function of endothelium in rats in vivo. Circ. Res. 80:1997;37-44.
16. Bassa B.V., Roh D.D., Kirschenbaum M.A., Kamanna V.S. Atherogenic lipoproteins stimulate mesangial cell p42 mitogen-activated protein kinase. J. Am. Soc. Nephrol. 9:1998;488-496.
17. Ha H., Roh D.D., Kirschenbaum M.A., Kamanna V.S. Atherogenic lipoproteins enhance mesangial cell expression of platelet-derived growth factor role of protein tyrosine kinase and cyclic AMP-dependent protein kinase A . J. Lab. Clin. Med. 131:1998;456-465.
18. Nishida Y., Oda H., Yorioka N. Effect of lipoproteins on mesangial cell proliferation. Kidney Int. Suppl. 71:1999;S51-S53.
19. Nishida Y., Yorioka N., Oda H., Yamakido M. Effect of lipoproteins on cultured human mesangial cells. Am. J. Kidney Dis. 29:1997;919-930.
20. Wheeler D.C., Chana R.S., Topley N., Petersen M.M., Davies M., Williams J.D. Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury. Kidney Int. 45:1994;1628-1636.
21. Berliner J.A., Territo M.C., Sevanian A., Ramin S., Kim J.A., Bamshad B., Esterson M., Fogelman A.M. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85:1990;1260-1266.
22. 2 stimulates vascular smooth muscle hypertrophy by up-regulating the synthesis and release of endogenous basic fibroblast growth factor. J. Biol. Chem. 268:1993;17397-17403.
23. Heinecke J.W., Rosen H., Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J. Clin. Invest. 74:1984;1890-1894.
24. Ehrenwald E., Chisolm G.M., Fox P.L. Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J. Clin. Invest. 93:1994;1493-1501.
25. Balla G., Jacob H.S., Eaton J.W., Belcher J.D., Vercellotti G.M. Hemin A possible physiological mediator of low density lipoprotein oxidation and endothelial injury . Arterioscler. Thromb. 11:1991;1700-1711.
26. Negre-Salvayre A., Lopez M., Levade T., Pieraggi M.-T., Dousset N., Douste-Blazy L., Salvayre R. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cell. II. Uptake and cytotoxicity of ultraviolet-treated LDL on lymphoid cell lines. Biochim. Biophys. Acta. 1045:1990;224-232.
27. Cathcart M.K., McNally A.K., Chisolm G.M. Lipoxygenase-mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex. J. Lipid Res. 32:1991;63-70.
28. Savenkova M.L., Mueller D.M., Heinecke J.W. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J. Biol. Chem. 269:1994;20394-20400.
29. Cathcart M.K., Morel D.W., Chisolm G.M. Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. J. Leukoc. Biol. 38:1985;341-350.
30. Hodis H.N., Kramsch D.M., Avogaro P., Bittolo-Bon G., Cazzolato G., Hwang J., Peterson H., Sevanian A. Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-). J. Lipid Res. 35:1994;669-677.
31. Morel D.W., Chisolm G.M. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J. Lipid Res. 30:1989;1827-1834.
32. Hoff, H. F.; Chisolm, G. M.; Morel, D. W.; Jürgens, G.; Esterbauer, H. Chemical and functional changes in LDL following modification by 4-hydroxynonenal. In: Cerutti, P. A.; Fredovich, I.; McCord, J. M., eds Oxy-radicals in molecular biology and pathology. New York: Alan R. Liss, Inc.; 1988:459-472.
33. Yla-Herttuala S., Palinski W., Rosenfeld M.E., Parthasarathy S., Carew T.E., Butler S., Witztum J.L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1989;1086-1095.
34. Chisolm G.M. III, Hazen S.L., Fox P.L., Cathcart M.K. The oxidation of lipoproteins by monocytes-macrophages. Biochemical and biological mechanisms. J. Biol. Chem. 274:1999;25959-25962.
35. Chatterjee S. Role of oxidized human plasma low density lipoproteins in atherosclerosis effects on smooth muscle cell proliferation . Mol. Cell. Biochem. 111:1992;143-147.
36. Lafont A.M., Chai Y.C., Cornhill J.F., Whitlow P.L., Howe P.H., Chisolm G.M. Effect of alpha-tocopherol on restenosis after angioplasty in a model of experimental atherosclerosis. J. Clin. Invest. 95:1995;1018-1025.
37. Chai Y.C., Howe P.H., DiCorleto P.E., Chisolm G.M. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells evidence for release of FGF-2 . J. Biol. Chem. 271:1996;17791-17797.
38. Heery J.M., Kozak M., Stafforini D.M., Jones D.A., Zimmerman G.A., McIntyre T.M., Prescott S.M. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J. Clin. Invest. 96:1995;2322-2330.
39. Colles S.M., Irwin K.C., Chisolm G.M. Roles of multiple oxidized LDL lipids in cellular injury dominance of 7 beta-hydroperoxycholesterol . J. Lipid Res. 37:1996;2018-2028.
40. Hughes H., Mathews B., Lenz M.L., Guyton J.R. Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol. Arterioscler. Thromb. 14:1994;1177-1185.
41. Sevanian A., Hodis H.N., Hwang J., McLeod L.L., Peterson H. Characterization of endothelial cell injury by cholesterol oxidation products found in oxidized LDL. J. Lipid Res. 36:1995;1971-1986.
42. Oinuma T., Yamada T., Sakurai I. Effects of copper-zinc type superoxide dismutase on the proliferation and migration of cultured vascular smooth muscle cells induced by oxidized low density lipoprotein. J. Atheroscler. Thromb. 4:1997;79-84.
43. Stiko A., Regnstrom J., Shah K., Cercek B., Nilsson J. Active oxygen species and lysophosphatidylcholine are involved in oxidized low density lipoprotein activation of smooth muscle cell DNA synthesis. Arterioscler. Thromb. Vasc. Biol. 16:1996;194-200.
44. Chatterjee S. Sphingolipids in atherosclerosis and vascular biology. Arterioscler. Thromb. Vasc. Biol. 18:1998;1523-1533.
45. Chatterjee S. Lactosylceramide stimulates aortic smooth muscle cell proliferation. Biochem. Biophys. Res. Commun. 181:1991;554-561.
46. Chatterjee S., Ghosh N. Oxidized low density lipoprotein stimulates aortic smooth muscle cell proliferation. Glycobiology. 6:1996;303-311.
47. Bhunia A.K., Han H., Snowden A., Chatterjee S. Lactosylceramide stimulates Ras-GTP loading, kinases (MEK, Raf), p44 mitogen-activated protein kinase, and c-fos expression in human aortic smooth muscle cells. J. Biol. Chem. 271:1996;10660-10666.
48. Balagopalakrishna C., Bhunia A.K., Rifkind J.M., Chatterjee S. Minimally modified low density lipoproteins induce aortic smooth muscle cell proliferation via the activation of mitogen activated protein kinase. Mol. Cell Biochem. 170:1997;85-89.
49. Bhunia A.K., Han H., Snowden A., Chatterjee S. Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells. J. Biol. Chem. 272:1997;15642-15649.
50. 44 mitogen activated protein kinase and c-fos expression in aortic smooth muscle cells. Glycobiology. 7:1997;703-710.
51. Auge N., Andrieu N., Negre-Salvayre A., Thiers J.C., Levade T., Salvayre R. The sphingomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation. J. Biol. Chem. 271:1996;19251-19255.
52. Auge N., Escargueil-Blanc I., Lajoie-Mazenc I., Suc I., Andrieu-Abadie N., Pieraggi M.T., Chatelut M., Thiers J.C., Jaffrezou J.P., Laurent G., Levade T., Negre-Salvayre A., Salvayre R. Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein. J. Biol. Chem. 273:1998;12893-12900.
53. Auge N., Nikolova-Karakashian M., Carpentier S., Parthasarathy S., Negre-Salvayre A., Salvayre R., Merrill A.H. Jr, Levade T. Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase. J. Biol. Chem. 274:1999;21533-21538.
54. Spiegel S., Cuvillier O., Edsall L.C., Kohama T., Menzeleev R., Olah Z., Olivera A., Pirianov G., Thomas D.M., Tu Z., Van Brocklyn J.R., Wang F. Sphingosine-1-phosphate in cell growth and cell death. Ann. NY Acad. Sci. 845:1998;11-18.
55. Ruef J., Rao G.N., Li F., Bode C., Patterson C., Bhatnagar A., Runge M.S. Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal. Circulation. 97:1998;1071-1078.
56. Chai, Y. C.; Binion, D. G.; Chisolm, G. M. Effect of molecular structure on the mechanism of lysophospholipid-induced smooth muscle cell proliferation. Amer. J. Physiol. Heart Circ. Physiol. In press; 2000.
57. Marathe G.K., Davies S.S., Harrison K.A., Silva A.R., Murphy R.C., Castro-Faria-Neto H., Prescott S.M., Zimmerman G.A., McIntyre T.M. Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines. J. Biol. Chem. 274:1999;28395-28404.
58. Chai, Y. C.; Howe, P. H.; DiCorleto, P. E.; Chisolm, G. M. Oxidized low density lipoprotein and lysophosphatidylcholine stimulation of DNA synthesis in vascular smooth muscle cells appears mediated by basic fibroblast growth factor. Circulation 92:I288 (abstract); 1995.
59. 2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells. Atherosclerosis. 112:1995;69-76.
60. Weltzien H.U. Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim. Biophys. Acta. 559:1979;259-287.
61. Chai, Y. C.; Binion, D. G.; Chisolm, G. M. Specificity and cellular mechanism of lysophatidylcholine stimulation of vascular smooth muscle cell growth. Circulation 96:111 (abstract); 1997.
62. Durante W., Liao L., Peyton K.J., Schefer A.I. Lysophosphatidylcholine regulates cationic amino acid transport and metabolism in vascular smooth muscle cells. Role in polyamine biosynthesis. J. Biol. Chem. 272:1997;30154-30159.
63. Esterbauer H., Jürgens G., Quehenberger O., Koller E. Autoxidation of human low density lipoprotein loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes . J. Lipid Res. 28:1987;495-509.
64. Jürgens G., Hoff H.F., Chisolm G.M., Esterbauer H. Modification of human serum low density lipoprotein by oxidation - characterization and pathophysiologic implications. Chem. Phys. Lipids. 45:1987;315-336.
65. Rao G.N., Alexander R.W., Runge M.S. Linoleic acid and its metabolites, hydroperoxyoctadecadienoic acids, stimulate c-Fos, c-Jun and c-Myc mRNA expression, mitogen-activated protein kinase activation, and growth in rat aortic smooth muscle cells. J. Clin. Invest. 96:1995;842-847.
66. Rao G.N., Baas A.S., Glasgow W.C., Eling T.E., Runge M.S., Alexander R.W. Activation of mitogen-activated protein kinases by arachidonic acid and its metabolites in vascular smooth muscle cells. J. Biol. Chem. 269:1994;32586-32591.
67. Kraemer R., Pomerantz K.B., Joseph-Silverstein J., Hajjar D.P. Induction of basic fibroblast growth factor mRNA and protein synthesis in smooth muscle cells by cholesterol ester enrichment and 25-hydroxycholesterol. J. Biol. Chem. 268:1993;8040-8045.
68. Ananyeva N.M., Tjurmin A.V., Berliner J.A., Chisolm G.M., Liau G., Winkles J.A., Haudenschild C.C. Oxidized LDL mediates the release of fibroblast growth factor-1. Arterioscler. Thromb. Vasc. Biol. 17:1997;445-453.
69. Zwijsen R.M., Japenga S.C., Heijen A.M.P., Van den Bos R.C., Koeman J.H. Induction of platelet-derived growth factor chain A gene expression in human smooth muscle cells by oxidized low density lipoproteins. Biochem. Biophys. Res. Commun. 186:1992;1410-1416.
70. Stiko-Rahm A., Hultgardh-Nilsson A., Regnstrom J., Hamsten A., Nilsson J. Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells. Arterioscler. Thromb. 12:1992;1099-1109.
71. Ohara Y., Peterson T.E., Zheng B., Kuo J.F., Harrison D.G. Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation. Arterioscler. Thromb. 14:1994;1007-1013.
72. Burdon R.H., Gill V., Rice-Evans C. Cell proliferation and oxidative stress. Free Radic. Res. Commun. 7:1989;149-159.
73. Murrell G.A., Francis M.J., Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem. J. 265:1990;659-665.
74. Rao G.N., Berk B.C. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ. Res. 70:1992;593-599.
75. 2 for vascular smooth muscle cells is mediated by an increase of the affinity of basic fibroblast growth factor for its receptor. FEBS Lett. 395:1996;43-47.
76. Bird D.A., Gillotte K.L., Horkko S., Friedman P., Dennis E.A., Witztum J.L., Steinberg D. Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties implications with respect to macrophage recognition of apoptotic cells . Proc. Natl. Acad. Sci. USA. 96:1999;6347-6352.
77. Zhu Y., Lin J.H., Liao H.L., Verna L., Stemerman M.B. Activation of ICAM-1 promoter by lysophosphatidylcholine possible involvement of protein tyrosine kinases . Biochim. Biophys. Acta. 1345:1997;93-98.
78. Katsuda S., Coltrera M.D., Ross R., Gown A.M. Human atherosclerosis. IV. Immunocytochemical analysis of cell activation and proliferation in lesions of young adults. Am. J. Pathol. 142:1993;1787-1793.
79. Rekhter M.D., Gordon D. Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. Am. J. Pathol. 147:1995;668-677.
80. Rosenfeld M.E., Ross R. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 10:1990;680-687.
81. Yui S., Sasaki T., Miyazaki A., Horiuchi S., Yamazaki M. Induction of murine macrophage growth by modified LDLs. Arterioscler. Thromb. 13:1993;331-337.
82. Sakai M., Miyazaki A., Hakamata H., Sasaki T., Yui S., Yamazaki M., Shichiri M., Horiuchi S. Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J. Biol. Chem. 269:1994;31430-31435.
83. Sakai M., Miyazaki A., Hakamata H., Sato Y., Matsumura T., Kobori S., Shichiri M., Horiuchi S. Lysophosphatidylcholine potentiates the mitogenic activity of modified LDL for human monocyte-derived macrophages. Arterioscler. Thromb. Vasc. Biol. 16:1996;600-605.
84. Biwa, T.; Hakamata, H.; Sakai, M.; Miyazaki, A.; Suzuki, H.; Kodama, T.; Shichiri, M.; Horiuchi, S. Induction of murine macrophage growth by oxidized low density lipoprotein is mediated by granulocyte macrophage colony-stimulating factor. J. Biol. Chem. 273:28305-28313;
85. Martens J.S., Lougheed M., Gomez-Munoz A., Steinbrecher U.P. A modification of apolipoprotein B accounts for most of the induction of macrophage growth by oxidized low density lipoprotein. J. Biol. Chem. 274:1999;10903-10910.
86. Sakai M., Miyazaki A., Hakamata H., Kodama T., Suzuki H., Kobori S., Shichiri M., Horiuchi S. The scavenger receptor serves as a route for internalization of lysophosphatidylcholine in oxidized low density lipoprotein-induced macrophage proliferation. J. Biol. Chem. 271:1996;27346-27352.
87. Martens J.S., Reiner N.E., Herrera-Velit P., Steinbrecher U.P. Phosphatidylinositol 3-kinase is involved in the induction of macrophage growth by oxidized low density lipoprotein. J. Biol. Chem. 273:1998;4915-4920.
88. Matsumura T., Sakai M., Kobori S., Biwa T., Takemura T., Matsuda H., Hakamata H., Horiuchi S., Shichiri M. Two intracellular signaling pathways for activation of protein kinase C are involved in oxidized low-density lipoprotein-induced macrophage growth. Arterioscler. Thromb. Vasc. Biol. 17:1997;3013-3020.
89. Fyrnys B., Claus R., Wolf G., Deigner H.P. Oxidized low density lipoprotein stimulates protein kinase C (PKC) activity and expression of PKC-isotypes via prostaglandin-H-synthase in P388D1 cells. Adv. Exp. Med. Biol. 407:1997;93-98.
90. Kusuhara M., Chait A., Cader A., Berk B.C. Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages. Arterioscler. Thromb. Vasc. Biol. 17:1997;141-148.
91. Deigner H.P., Claus R. Stimulation of mitogen activated protein kinase by LDL and oxLDL in human U-937 macrophage-like cells. FEBS Lett. 385:1996;149-153.
92. Sakai M., Kobori S., Matsumura T., Biwa T., Sato Y., Takemura T., Hakamata H., Horiuchi S., Shichiri M. HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein. Atherosclerosis. 133:1997;51-59.
93. Sakai M., Biwa T., Matsumura T., Takemura T., Matsuda H., Anami Y., Sasahara T., Kobori S., Shichiri M. Glucocorticoid inhibits oxidized LDL-induced macrophage growth by suppressing the expression of granulocyte/macrophage colony-stimulating factor. Arterioscler. Thromb. Vasc. Biol. 19:1999;1726-1733.
94. Yui S., Sasaki T., Araki N., Horiuchi S., Yamazaki M. Induction of macrophage growth by advanced glycation end products of the maillard reaction. J. Immunol. 152:1994;1943-1949.
95. Schuh J., Novogrodsky A., Haschemeyer R.H. Inhibition of lymphocyte mitogenesis by autoxidized low-density lipoprotein. Biochem. Biophys. Res. Commun. 84:1978;763-768.
96. Chisolm G.M., Ma G., Irwin K.C., Martin L.L., Gunderson K.G., Linberg L.F., Morel D.W., DiCorleto P.E. 7 beta-hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. Proc. Natl. Acad. Sci. USA. 91:1994;11452-11456.
97. Borsum T., Henriksen B., Carlander B., Reisvaag A. Injury to human cells in culture induced by low density lipoprotein an effect independent of receptor binding and endocytotic uptake of low density lipoprotein . Scand. J. Clin. Lab. Invest. 42:1982;75-81.
98. Coffey M.D., Cole R.A., Colles S.M., Chisolm G.M. In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals. J. Clin. Invest. 96:1995;1866-1873.
99. Negre-Salvayre A., Alomar Y., Troly M., Salvayre R. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. III. The protective effect of antioxidants (probucol, catechin, vitamin E) against the cytotoxicity of oxidized LDL occurs in two different ways. Biochim. Biophys. Acta. 1096:1991;291-300.
100. Henriksen T., Evensen S.A., Carlander B. Injury to cultured endothelial cells induced by low density lipoproteins protection by high density lipoproteins . Scand. J. Clin. Lab. Invest. 39:1979;369-375.
101. Sata M., Walsh K. Oxidized LDL activates Fas-mediated endothelial cell apoptosis. J. Clin. Invest. 102:1998;1682-1689.
102. Escargueil-Blanc I., Salvayre R., Negre-Salvayre A. Necrosis and apoptosis induced by oxidized low density lipoproteins occur through two calcium-dependent pathways in lymphoblastoid cells. FASEB J. 8:1994;1075-1080.
103. Lizard G., Lemaire S., Monier S., Gueldry S., Neel D., Gambert P. Induction of apoptosis and of interleukin-1beta secretion by 7beta-hydroxycholesterol and 7-ketocholesterol partial inhibition by Bcl-2 overexpression . FEBS Lett. 419:1997;276-280.
104. Reid V.C., Mitchinson M.J., Skepper J.N. Cytotoxicity of oxidized low-density lipoprotein to mouse peritoneal macrophages an ultrastructural study . J. Pathol. 171:1993;321-328.
105. Sugawa M., Ikeda S., Kushima Y., Takashima Y., Cynshi O. Oxidized low density lipoprotein caused CNS neuron cell death. Brain Res. 761:1997;165-172.
106. Chisolm, G.M.; Penn, M.S. Oxidized lipoproteins and atherosclerosis. In: Fuster, V.; Ross, R.; Topol, E. J., eds. Atherosclerosis and coronary artery disease. New York: Raven Press; 1996:129-149.
107. Chisolm G.M. Cytotoxicity of oxidized lipoproteins. Curr. Opin. Lipidol. 2:1991;311-316.
108. Malden L.T., Chait A., Raines E.W., Ross R. The influence of oxidatively modified low density lipoproteins on expression of platelet-derived growth factor by human monocyte-derived macrophages. J. Biol. Chem. 266:1991;13901-13907.
109. Falciani, M.; Gori, A. M.; Fedi, S.; Chiarugi, L.; Simonetti, I.; Dabizzi, R. P.; Prisco, D.; Pepe, G.; Abbate, R.; Gensini, G. F.; Neri Serneri, G. G. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients. Thromb. Haemost. 79:495-499; 1998.
110. Kume N., Gimbrone M.A. Jr. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J. Clin. Invest. 93:1994;907-911.
111. Raab G., Klagsbrun M. Heparin-binding EGF-like growth factor. Biochim. Biophys. Acta. 1333:1997;F179-F199.
112. Nakano T., Raines E.W., Abraham J.A., Klagsbrun M., Ross R. Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proc. Natl. Acad. Sci. USA. 91:1994;1069-1073.
113. Ku G., Thomas C.E., Akeson A.L., Jackson R.L. Induction of interleukin 1β expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid. J. Biol. Chem. 267:1992;14183-14188.
114. Thomas C.E., Jackson R.L., Ohlweiler D.F., Ku G. Multiple lipid oxidation products in low density lipoproteins induce interleukin-1 beta release from human blood mononuclear cells. J. Lipid Res. 35:1994;417-427.
115. Prescott M.F., Muller K.R., Flammer R., Feige U. The effect of LDL and modified LDL on macrophage secretion products. Agents Actions Suppl. 16:1984;163-170.
116. Neuenschwander P.F., Morrissey J.H. Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. Analysis of a mutant with a selective deficiency in activity. J. Biol. Chem. 267:1992;14477-14482.
117. Molloy C.J., Taylor D.S., Pawlowski J.E. Novel cardiovascular actions of the activins. J. Endocrinol. 161:1999;179-185.
118. Jougasaki M., Kugiyama K., Saito Y., Nakao K., Imura H., Yasue H. Suppression of endothelin-1 secretion by lysophosphatidylcholine in oxidized low density lipoprotein in cultured vascular endothelial cells. Circ. Res. 71:1992;614-619.
119. He Y., Kwan W.C., Steinbrecher U.P. Effects of oxidized low density lipoprotein on endothelin secretion by cultured endothelial cells and macrophages. Atherosclerosis. 119:1996;107-118.
120. Boulanger C.M., Tanner F.C., Bea M.L., Hahn A.W.A., Werner A., Lüscher T.F. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ. Res. 70:1992;1191-1197.
121. Martin-Nizard F., Houssaini H.S., Lestavel-Delattre S., Duriez P., Fruchart J.C. Modified low density lipoproteins activate human macrophages to secrete immunoreactive endothelin. FEBS Lett. 293:1991;127-130.
122. Ramos M.A., Kuzuya M., Esaki T., Miura S., Satake S., Asai T., Kanda S., Hayashi T., Iguchi A. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 18:1998;1188-1196.
123. Terkeltaub R., Banka C.L., Solan J., Santoro D., Brand K., Curtiss L.K. Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arterioscler. Thromb. 14:1994;47-53.
124. Stemme S., Faber B., Holm J., Wiklund O., Witztum J.L., Hansson G.K. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA. 92:1995;3893-3897.
125. Hansen J.-B., Huseby N.-E., Sandset P.M., Svensson B., Lyngmo V., Nordoy A. Tissue-factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma. Arterioscler. Thromb. 14:1994;223-229.
126. Hamilton T.A., Major J.A., Armstrong D., Tebo J.M. Oxidized LDL modulates activation of NFkappaB in mononuclear phagocytes by altering the degradation of IkappaBs. J. Leukoc. Biol. 64:1998;667-674.
127. Hamilton T.A., Major J.A. Oxidized LDL potentiates LPS-induced transcription of the chemokine KC gene. J. Leukoc. Biol. 59:1996;940-947.
128. Hwang P.L. Inhibitors or protein and RNA synthesis block the cytotoxic effects of oxygenated sterols. Biochim. Biophys. Acta. 1136:1992;5-11.